- Report
- July 2021
- 112 Pages
Global
From €3187EUR$3,560USD£2,715GBP
€3984EUR$4,450USD£3,393GBP
- Report
- April 2024
- 140 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- September 2023
- 160 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- July 2023
- 140 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- June 2023
- 140 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- May 2023
- 140 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- May 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- February 2024
- 179 Pages
Global
From €2686EUR$3,000USD£2,288GBP
- Report
- January 2024
- 118 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- July 2023
- 115 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- September 2023
- 115 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- December 2023
- 231 Pages
Global
€4472EUR$4,995USD£3,809GBP
- Report
- December 2023
- 245 Pages
Global
€4472EUR$4,995USD£3,809GBP
- Report
- February 2024
- 234 Pages
Global
€4472EUR$4,995USD£3,809GBP
- Report
- January 2024
- 306 Pages
Global
€4472EUR$4,995USD£3,809GBP
- Report
- July 2023
- 300 Pages
Global
From €2238EUR$2,500USD£1,906GBP
- Report
- August 2023
- 51 Pages
India
From €403EUR$450USD£343GBP
€537EUR$600USD£458GBP
- Report
- August 2023
- 1350 Pages
Global
From €5975EUR$6,675USD£5,090GBP
€7967EUR$8,900USD£6,786GBP
- Report
- August 2023
- 300 Pages
Latin America
From €3290EUR$3,675USD£2,802GBP
€4386EUR$4,900USD£3,736GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €3290EUR$3,675USD£2,802GBP
€4386EUR$4,900USD£3,736GBP

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases.
Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field.
The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more